GOLDMAN SACHS GROUP INC - TONIX PHARMACEUTICALS HLDG C ownership

Back to all holdings Add to watchlist

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 44 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2022$18,000
+5.9%
34,182
+213.9%
0.00%–
Q2 2022$17,000–10,890–0.00%–
 Download
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 14$170.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders